The reduced expression of DNAM-1 has been observed in a variety of other cancers, including a recent report by Guillamon et al., showing lower overall survival in patients with solid tumors that exhibit a low expression of DNAM-1 on NK cells [31]. The gene discussed is CD226; the disease is cancer.